Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 225-876-3 | CAS number: 5131-58-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
LD50 was considered to be 1650 mg/kg (1380-1800) when SPF Wistar female rats were treated with 4-nitrobenzene-1,3-diamine orally by gavage.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study
- Justification for type of information:
- Data is from study report
- Qualifier:
- according to guideline
- Guideline:
- other: as below
- Principles of method if other than guideline:
- Studies on the acute oral toxicity of 4-nitro-1,3-phenylenediamine in female Wistar rats
- GLP compliance:
- not specified
- Test type:
- standard acute method
- Limit test:
- no
- Specific details on test material used for the study:
- - Name of test material (as cited in study report): 4-nitro-m-phenylenediamine
- Molecular formula (if other than submission substance): C6H7N3O2
- Molecular weight (if other than submission substance): 153.14 g/mole
- Substance type: Organic
- Physical state: Solid - Species:
- rat
- Strain:
- Wistar
- Remarks:
- SPF
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: SPF rats (Wistar strain TNO W 74, Ztichter: Winkelmann, Borchen)
- Age at study initiation: approximately 14 weeks old
- Weight at study initiation: average initial weight of 171 g.
- Fasting period before study: Not reported
- Housing: Conventional cages in Makrolon type III in a dust-free wood pellets in groups of 5 animals
- Diet (e.g. ad libitum): altromin R 1324, ad libitum
- Water (e.g. ad libitum): Tap water ad libitum
- Acclimation period: Not reported
- Identification: The identification of the animals was performed by picric acid marker of the skin and cage labeling
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22±1.5 ° C
- Humidity (%): 60 ± 5 %
- Air changes (per hr): Not reported
- Photoperiod (hrs dark / hrs light): 12 hour light / dark cycle (artificial lighting 7-19 hours)
IN-LIFE DATES: From: To: Not reported - Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- The substance was formulated at room temperature in water and administered by means of a rigid metal gavage at constant volume administered (20 ml / kg body weight) to 10 female animals/dose administered once.
- Doses:
- 1000, 1500, 2000, 2500, 3100 mg/kg bw
- No. of animals per sex per dose:
- Totel: 50
1000 mg/kg bw: 10 female
1500 mg/kg bw: 10 female
2000 mg/kg bw: 10 female
2500 mg/kg bw: 10 female
3100 mg/kg bw 10 female - Control animals:
- not specified
- Details on study design:
- On the day of application and in the following 14-day observation period, the animals were repeatedly inspected twice a day (once on weekends and holidays), for the nature, onset, duration and intensity of the clinical symptoms and possibly death.
Deaths and conclusion of the test animals slaughtered were randomly dissected
During the application and at the end of the 14 day observation period, the animals were weighed individually about living. - Statistics:
- The calculation of the LD50 with the confidence interval for p <0.05 was carried out with the programmed probit analysis by Fink and Hund
- Preliminary study:
- not specified
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 1 650 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 1 380 - 1 800
- Remarks on result:
- other: 50 % mortality observed
- Mortality:
- when treated with 3100 mg/kg bw, all animals died
when treated with 2500 mg/kg bw, 9 female rats were died.
when treated with 2000 mg/kg bw, 7 female rats were died.
when treated with 1500 mg/kg bw, 5 female rats were died.
when treated with 1000 mg/kg bw, No mortality were observed. - Clinical signs:
- other: Anesthesia, tremors, shaggy coat, stomach side position, reduction of the general condition, sedation were observed in treated female rats.
- Gross pathology:
- No macroscopically specific findings were observed in treated rats died during the experiment and some at the end of the experiment killed animals.
- Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- LD50 was considered to be 1650 mg/kg (1380-1800) when SPF Wistar female rats were treated with 4-nitrobenzene-1,3-diamine orally by gavage.
- Executive summary:
In a acute oral toxicity study, SPF Wistar female rats were treated with 4-nitrobenzene-1,3-diamine in the concentration of 1000, 1500, 2000, 2500, 3100 mg/kg bw orally by gavage. All animals died at 3100 mg/kg bw, 9 female rats were died at 2500 mg/kg bw, 7 female rats were died at 2000 mg/kg bw, 5 female rats were died at 1500 mg/kg bw and No mortality were observed at 1000 mg/kg bw. In addition, Anesthesia, tremors, shaggy coat, stomach side position, reduction of the general condition, sedation and weight loss were observed in treated female rats. No macroscopically specific gross findings were observed treated female rats. Therefore, LD50 was considered to be 1650 mg/kg (1380-1800) when SPF Wistar female rats were treated with 4-nitrobenzene-1,3-diamine orally by gavage.
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 1 650 mg/kg bw
- Quality of whole database:
- Data is Klimiach 1 and from study report
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Acute oral toxicity:
In different studies, 4-nitrobenzene-1,3-diamine has been investigated for acute oral toxicity to a greater or lesser extent. Often are the studies based on in vivo experiments data in rodents, i.e. most commonly in mice and rats for 4-nitrobenzene-1,3-diamine along with the study available on structurally similar read across substance 2-nitrobenzene-1,4-diamine (CAS no 5307-14-2).
In a experimental study conducted by Bayer AG Institute for Toxicology (L1384, T 4002138, 1982), SPF Wistar female rats were treated with 4-nitrobenzene-1,3-diamine in the concentration of 1000, 1500, 2000, 2500, 3100 mg/kg bw orally by gavage. All animals died at 3100 mg/kg bw, 9 female rats were died at 2500 mg/kg bw, 7 female rats were died at 2000 mg/kg bw, 5 female rats were died at 1500 mg/kg bw and No mortality were observed at 1000 mg/kg bw. In addition, Anesthesia, tremors, shaggy coat, stomach side position, reduction of the general condition, sedation and weight loss were observed in treated female rats. No macroscopically specific gross findings were observed treated female rats. Therefore, LD50 was considered to be 1650 mg/kg (1380-1800) when SPF Wistar female rats were treated with 4-nitrobenzene-1,3-diamine orally by gavage.
In another experimental study summarized by Cosmetic Ingredient Review (Journal of the American College of Toxicology, Volume 11, Number 4, 1992) by In a acute oral toxicity study, mice were treated with 4-nitrobenzene-1,3-diamine orally. 50 % mortality observed at 500 mg/kg bw in treated mice. Therefore, LD50 was considered to be 500 mg/kg bw when mice were treated with 4-nitrobenzene-1,3-diamine orally.
Also it is further supported experimental study conducted by Bayer AG Institute for Toxicology (L1384, T 4002138, 1982), SPF Wistar male rats were treated with 4-nitrobenzene-1,3-diamine in the concentration of 1000, 1500, 2000, 2500, 3100 mg/kg bw orally by gavage. All animals died at 3100 mg/kg bw, 8 male rats were died at 2500 mg/kg bw, 4 male rats were died 2000 mg/kg bw, 1 male rats were died at 1500 mg/kg bw and No mortality were observed at 1000 mg/kg bw. Sedation, anesthesia, abdominal / side position, tremor, rough coat, reduction of the general condition were observed in treated male rats. No macroscopically specific findings were observed in treated rats died during the experiment and some at the end of the experiment killed animals. Therefore, LD50 was considered to be 2050 mg/kg (1800- 2300) when SPF Wistar male rats were treated with 4-nitrobenzene-1,3-diamine orally by gavage.
Further it is supported by experimental study conducted by Lloyoet al(Food Cosmetics Toxicology. Vol. 15, pp. 607-610. 1977) on structurally similar read across substance 2-nitrobenzene-1,4-diamine (CAS no 5307-14-2), CFY male and female rats were treated with 2-nitrobenzene-1,4-diamine in the concentration of 1800 mg/kg (40 %) as solutions or suspensions in 0.5% aqueous gum tragacanth, containing 0.05% Na2SO3 orally by gavage. 50% mortality was observed in treated male and female rats at 1800 mg/kg bw. Lethargy and piloerection were observed in treated rat. Other reactions elicited by more than one of the test compounds included increased salivation, ataxia, fine body tremors, changes in respiratory rate, dieresis and diarrhea were observed in treated rat. Autopsy of the animals that died as a result of treatment revealed changes included darkening of the liver and kidneys, darkening or pallor of the spleen, haemorrhage of the lungs and intestines, and injection of the intestinal and mesenteric blood vessels. Autopsy of the survivor rats at the end of each experiment did not reveal any abnormalities indicative of residual systemic effects. Therefore, LD50 was considered to be 1800 mg/kg bw(1500-2300) when CFY male and female rats were treated with 2-nitrobenzene-1,4-diamine orally.
Thought, the LD50 2050 mg/kg value for male rat is available, since the female are more sensitive than male, the LD50 for 4-nitrobenzene-1, 3-diamine is considered to be 1650 mg/kg.
Thus, based on the above studies on 4-nitrobenzene-1, 3-diamine and its read across substances, it can be concluded that LD50 value is less than 2000 mg/kg bw. Thus, comparing this value with the criteria of CLP regulation, 4-nitrobenzene-1,3-diamine can be classified as “Category IV” of acute oral toxicity.
Justification for classification or non-classification
Based on the above predictions and studies on 4-nitrobenzene-1, 3-diamine and its read across substances, it can be concluded that LD50 value is less than 2000 mg/kg bw. Thus, comparing this value with the criteria of CLP regulation, 4-nitrobenzene-1,3-diamine can be classified as “Category IV” of acute oral toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.